Clinical Trials Directory

Trials / Completed

CompletedNCT04347564

Usability of the Software MacuFix for the Categorization of Metamorphopsia

Usability of the Software MacuFix for the Categorization of Metamorphopsia and Evaluation of Patient Adherence Compared to the Amsler Grid

Status
Completed
Phase
Study type
Observational
Enrollment
45 (actual)
Sponsor
Augenheilkunde Lindenthal · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The usability of a novel test to categorize a distorted visual impression (metamorphopsia) is examined with the questionnaire "SUS"

Detailed description

Introduction Diseases of the retinal centre (macula) can lead to a distorted visual impression (metamorphopsia). The usability of a novel on-screen test to categorize metamorphopsia is to be examined with the questionnaire "SUS" to determine how user-friendly the software is perceived. Purpose To examine the usability of the software for persons perceiving metamorphopsia employing the questionnaire SUS. Aim of the work Improvement of the software in terms of user-friendliness. Methods For this observational pilot study, 30 persons are to be recruited from the patient pool of a private practice. Primary endpoint: Score of the SUS questionnaire. Each participating person performs the test once with each eye wearing appropriate near correction. The test shows on a screen 4 square fields with a grid pattern of horizontal and vertical lines. All 4 fields have lines that are partially distorted. The task of the test person is to select the field with more distinctively distorted lines when viewed with one eye.This selection must be made at least 10 times per eye: an algorithm determines the smallest correctly named distortion difference. Afterwards each person answers the System Usability Scale (SUS) questionnaire, SUS contains five positive and five negative statements on the usability of the system being evaluated. For each statement, the study participant gives his or her approval or rejection in the form of a scale ranging from 1= "strong approval" to 5= "strong rejection" of the statement. The results of the SUS questionnaire are used to calculate a numerical value (SUS score).

Conditions

Timeline

Start date
2020-05-04
Primary completion
2020-09-30
Completion
2020-09-30
First posted
2020-04-15
Last updated
2021-05-18
Results posted
2021-05-18

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04347564. Inclusion in this directory is not an endorsement.